BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 9, Issue 5
This Article
Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (4335)
All Articles published online
The chart showing PDF series, HTML series, Tables (1-7) series.
Item 
Count 
PDF466
HTML3669
Tables (1-7)188
 Sum=4323
May 15, 2003 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Shen L, Fan JG, Shao Y, Zeng MD, Wang JR, Luo GH, Li JQ, Chen SY. Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey. World J Gastroenterol 2003; 9(5): 1106-1110 [PMID: 12717867 DOI: 10.3748/wjg.v9.i5.1106]
URL: https://www.wjgnet.com/1007-9327/full/v9/i5/1106.htm
Number Citing Articles
1
ANKITA CHATTERJEE, ANALABHA BASU, ABHIJIT CHOWDHURY, KAUSIK DAS, NEETA SARKAR-ROY, PARTHA P. MAJUMDER, PRIYADARSHI BASU. Comparative analyses of genetic risk prediction methods reveal extreme diversity of genetic predisposition to nonalcoholic fatty liver disease (NAFLD) among ethnic populations of India. Journal of Genetics 2015; 94(1): 105 doi: 10.1007/s12041-015-0494-0
2
Sara Ashtari, Mohamad Amin Pourhoseingholi, Mohamad Reza Zali. Non-alcohol fatty liver disease in Asia: Prevention and planning. World Journal of Hepatology 2015; 7(13): 1788-1796 doi: 10.4254/wjh.v7.i13.1788
3
Leon A. Adams, Keith D. Lindor. Nonalcoholic Fatty Liver Disease. Annals of Epidemiology 2007; 17(11): 863 doi: 10.1016/j.annepidem.2007.05.013
4
N. J. BARSHOP, C. B. SIRLIN, J. B. SCHWIMMER, J. E. LAVINE. Review article: epidemiology, pathogenesis and potential treatments of paediatric non‐alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics 2008; 28(1): 13 doi: 10.1111/j.1365-2036.2008.03703.x
5
Huiling Wu, Xi Song, Yuntao Ling, Jin Zhou, Zhen Tao, Yuying Shen. Comprehensive bioinformatics analysis of critical lncRNAs, mRNAs and miRNAs in non‑alcoholic fatty liver disease. Molecular Medicine Reports 2019;  doi: 10.3892/mmr.2019.9931
6
Jian-Gao Fan, Lan Zhong, Li-Yan Tia, Zheng-Jie Xu, Min-Sheng Li, Guo-Liang Wang. Effects of ursodeoxycholic acid and/or low-calorie diet on steatohepatitis in rats with obesity and hyperlipidemia. World Journal of Gastroenterology 2005; 11(15): 2346-2350 doi: 10.3748/wjg.v11.i15.2346
7
Hiroshi Sakugawa, Tomofumi Nakayoshi, Kasen Kobashigawa, Tsuyoshi Yamashiro, Tatsuji Maeshiro, Satoru Miyagi, Joji Shiroma, Akiyo Toyama, Tomokuni Nakayoshi, Fukunori Kinjo, Atsushi Saito. Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease. World Journal of Gastroenterology 2005; 11(2): 255-259 doi: 10.3748/wjg.v11.i2.255
8
Janus P. Ong, Zobair M. Younossi. Approach to the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease. Clinics in Liver Disease 2005; 9(4): 617 doi: 10.1016/j.cld.2005.07.002
9
Amedeo Lonardo, Cesare Carani, Nicola Carulli, Paola Loria. ‘Endocrine NAFLD’ a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis. Journal of Hepatology 2006; 44(6): 1196 doi: 10.1016/j.jhep.2006.03.005
10
Einar Björnsson, Paul Angulo. Non-alcoholic fatty liver disease. Scandinavian Journal of Gastroenterology 2007; 42(9): 1023 doi: 10.1080/00365520701514529
11
Jie Hu, Wei Hong, Kan-Nan Yao, Xiao-Hong Zhu, Zhi-Yun Chen, Lei Ye. Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway. World Journal of Gastroenterology 2019; 25(12): 1492-1501 doi: 10.3748/wjg.v25.i12.1492
12
Jiwon Kim, Minyoung Lee, Soo Yeon Kim, Ji-Hye Kim, Ji Sun Nam, Sung Wan Chun, Se Eun Park, Kwang Joon Kim, Yong-ho Lee, Joo Young Nam, Eun Seok Kang. Non-Laboratory-Based Simple Screening Model for Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Developed Using Multi-Center Cohorts. Endocrinology and Metabolism 2021; 36(4): 823 doi: 10.3803/EnM.2021.1074
13
Jian‐Gao Fan, Feng Li, Xiao‐Bo Cai, Yong‐De Peng, Qing‐Hong Ao, Yan Gao. The importance of metabolic factors for the increasing prevalence of fatty liver in Shanghai factory workers. Journal of Gastroenterology and Hepatology 2007; 22(5): 663 doi: 10.1111/j.1440-1746.2007.04892.x
14
Wang Nanyue, Yu Youhua, Huang Dawei, Xu Bin, Liu Jia, Li Tongda, Xue Liyuan, Shan Zengyu, Chen Yanping, Wang Jia, Zhaohui Liang. Pulse Diagnosis Signals Analysis of Fatty Liver Disease and Cirrhosis Patients by Using Machine Learning. The Scientific World Journal 2015; 2015(1) doi: 10.1155/2015/859192
15
Mi Jin Bae, In Ho Oh, Jeon Su Park, Sang-Yeoup Lee, Jeong Gyu Lee, Yun Jin Kim, Dong-Wook Jung, Yu-Hyeon Yi, Young-Hye Cho, Eun Jung Choi. The Association between Elevated GGT with Alcohol Consumption and with Insulin Resistance. The Korean Journal of Obesity 2011; 20(3): 113 doi: 10.7570/kjo.2011.20.3.113
16
Thomas Jensen, Amanda Wieland, Melanie Cree-Green, Kristen Nadeau, Shelby Sullivan. Clinical workup of fatty liver for the primary care provider. Postgraduate Medicine 2019; 131(1): 19 doi: 10.1080/00325481.2019.1546532
17
Xiong MA, Zhiping LI. Pathogenesis of nonalcoholic steatohepatitis (NASH). Chinese Journal of Digestive Diseases 2006; 7(1): 7 doi: 10.1111/j.1443-9573.2006.00237.x
18
Young-Min Kwon, Seung-Won Oh, Seung-sik Hwang, CheolMin Lee, Hyuktae Kwon, Goh Eun Chung. Association of Nonalcoholic Fatty Liver Disease With Components of Metabolic Syndrome According to Body Mass Index in Korean Adults. American Journal of Gastroenterology 2012; 107(12): 1852 doi: 10.1038/ajg.2012.314
19
SEUNG H PARK, WOO K JEON, SANG H KIM, HONG J KIM, DONG I PARK, YONG K CHO, IN K SUNG, CHONG I SOHN, DONG K KEUM, BYUNG I KIM. Prevalence and risk factors of non‐alcoholic fatty liver disease among Korean adults. Journal of Gastroenterology and Hepatology 2006; 21(1): 138 doi: 10.1111/j.1440-1746.2005.04086.x
20
Chien-Hsien Wu, Ting-Yu Chang, Yen-Chu Chen, Rwei-Fen S. Huang. PEMT rs7946 Polymorphism and Sex Modify the Effect of Adequate Dietary Choline Intake on the Risk of Hepatic Steatosis in Older Patients with Metabolic Disorders. Nutrients 2023; 15(14): 3211 doi: 10.3390/nu15143211
21
Briohny W. Smith, Leon A. Adams. Non-alcoholic fatty liver disease. Critical Reviews in Clinical Laboratory Sciences 2011; 48(3): 97 doi: 10.3109/10408363.2011.596521
22
Moushira Zaki, Darine Amin, Ramy Mohamed. Body composition, phenotype and central obesity indices in Egyptian women with non-alcoholic fatty liver disease. Journal of Complementary and Integrative Medicine 2021; 18(2): 385 doi: 10.1515/jcim-2020-0073
23
Chi Wang, Zhen-yu Jiang, Jing Wang, Jia-xin Lou, Yuan-yuan Nian, Lixia Liu, Tong Dang, Xian-Mei Meng. A Small H <sub>2</sub>O-Soluble Ingredient of Royal Jelly Lower Cholesterol Levels in Liver Cells by Suppressing Squalene Epoxidase. SSRN Electronic Journal 2022;  doi: 10.2139/ssrn.4198937
24
Nicole Fakhoury Sayegh, Gessica N. H. A. Heraoui, Hassan Younes, Lea Nicole Sayegh, Christa Boulos, Raymond Sayegh. Relation of Dietary Patterns and Nutritional Profile to Hepatic Fibrosis in a Sample of Lebanese Non-Alcoholic Fatty Liver Disease Patients. Nutrients 2022; 14(12): 2554 doi: 10.3390/nu14122554
25
Sanjaya Kumar Satapathy, Satheesh Nair, Jason M. Vanatta. Nonalcoholic fatty liver disease following liver transplantation. Hepatology International 2013; 7(2): 400 doi: 10.1007/s12072-013-9434-3
26
Jian-Gao Fan, Lan Zhong, Zheng-Jie Xu, Li-Yan Tia, Xiao-Dong Ding, Min-Sheng Li, Guo-Liang Wang. Effects of low-calorie diet on steatohepatitis in rats with obesity and hyperlipidemia. World Journal of Gastroenterology 2003; 9(9): 2045-2049 doi: 10.3748/wjg.v9.i9.2045
27
Smruti R. Mohanty, Tara N. Troy, Dezheng Huo, Bridget L. O’Brien, Donald M. Jensen, John Hart. Influence of ethnicity on histological differences in non-alcoholic fatty liver disease. Journal of Hepatology 2009; 50(4): 797 doi: 10.1016/j.jhep.2008.11.017
28
JINYAN ZHAO, HAIYIN ZHENG, YAN LIU, JIUMAO LIN, XIAOYONG ZHONG, WEI XU, ZHENFENG HONG, JUN PENG. Anti-inflammatory effects of total alkaloids from Rubus aleaefolius Poir. on non-alcoholic fatty liver disease through regulation of the NF-κB pathway. International Journal of Molecular Medicine 2013; 31(4): 931 doi: 10.3892/ijmm.2013.1281
29
Okka W. Hamer, Diego A. Aguirre, Giovanna Casola, Joel E. Lavine, Matthias Woenckhaus, Claude B. Sirlin. Fatty Liver: Imaging Patterns and Pitfalls. RadioGraphics 2006; 26(6): 1637 doi: 10.1148/rg.266065004
30
Vasundhara Devi D, Madhu Latha M, Sumapreethi A, Sharma S.S.B, Priyanka M. A STUDY OF NON ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH METABOLIC SYNDROME. Journal of Evolution of medical and Dental Sciences 2013; 2(4): 375 doi: 10.14260/jemds/272
31
Yansong Lin, Xiongcai Feng, Xu Cao, Rong Miao, Yanhong Sun, Rui Li, Junzhao Ye, Bihui Zhong. Age patterns of nonalcoholic fatty liver disease incidence: heterogeneous associations with metabolic changes. Diabetology & Metabolic Syndrome 2022; 14(1) doi: 10.1186/s13098-022-00930-w
32
Sebastian Varghese, Krishna Chaitanya Nunna. SONOGRAPHIC CORRELATION OF CAROTID INTIMA MEDIA THICKNESS AND HEPATIC ECHOTEXTURE WITH SERUM LIPID PROFILE. Journal of Evolution of Medical and Dental Sciences 2018; 7(30): 3380 doi: 10.14260/jemds/2018/763
33
Cheng‐Hung Chien, Chia‐Ying Yu, Li‐Wei Chen, Chih‐Lang Lin, Yu‐Chiau Shyu, Shuo‐Wei Chen, Ching‐Chih Hu, Rong‐Nan Chien. The prevalence and etiology of elevated aminotransferase levels in northeastern Taiwan: A community‐based study. Advances in Digestive Medicine 2021; 8(2): 75 doi: 10.1002/aid2.13197
34
Swastik Agrawal, Ajay K Duseja. Non-alcoholic Fatty Liver Disease: East Versus West. Journal of Clinical and Experimental Hepatology 2012; 2(2): 122 doi: 10.1016/S0973-6883(12)60101-7
35
Chen-Chung Fu, Ming-Chen Chen, Yin-Ming Li, Tso-Tsai Liu, Li-Yu Wang. The Risk Factors for Ultrasound-diagnosed Non-alcoholic Fatty Liver Disease Among Adolescents. Annals of the Academy of Medicine, Singapore 2009; 38(1): 15 doi: 10.47102/annals-acadmedsg.V38N1p15
36
Stefano Ballestri, Fabio Nascimbeni, Enrica Baldelli, Alessandra Marrazzo, Dante Romagnoli, Amedeo Lonardo. NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk. Advances in Therapy 2017; 34(6): 1291 doi: 10.1007/s12325-017-0556-1
37
Armin Imhof, Wolfgang Kratzer, Bernhard Boehm, Katrin Meitinger, Gerlinde Trischler, Gerald Steinbach, Isolde Piechotowski, Wolfgang Koenig. Prevalence of non-alcoholic fatty liver and characteristics in overweight adolescents in the general population. European Journal of Epidemiology 2007; 22(12): 889 doi: 10.1007/s10654-007-9181-7
38
Santosh Kumar, Sreyoshi F. Alam, Paul K. Ganguly. Pathophysiology of Obesity-Induced Health Complications. 2020; : 181 doi: 10.1007/978-3-030-35358-2_11
39
Jian-Gao Fan, Jun Zhu, Xing-Jian Li, Lan Chen, Lui Li, Fei Dai, Feng Li, Shi-Yao Chen. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. Journal of Hepatology 2005; 43(3): 508 doi: 10.1016/j.jhep.2005.02.042
40
Jorge-Shmuel Delgado. Evolving trends in nonalcoholic fatty liver disease. European Journal of Internal Medicine 2008; 19(2): 75 doi: 10.1016/j.ejim.2007.02.034
41
Marco Bertolotti, Amedeo Lonardo, Chiara Mussi, Enrica Baldelli, Elisa Pellegrini, Stefano Ballestri, Dante Romagnoli, Paola Loria. Nonalcoholic fatty liver disease and aging: Epidemiology to management. World Journal of Gastroenterology 2014; 20(39): 14185-14204 doi: 10.3748/wjg.v20.i39.14185
42
Mustafa Koplay, Mustafa Gok, Mesut Sivri. The association between coronary artery disease and nonalcoholic fatty liver disease and noninvasive imaging methods. Electronic Journal of General Medicine 2019; 16(6): em165 doi: 10.29333/ejgm/110689
43
Shi-Jun Zhang, Ze-Xiong Chen, Kai-Ping Jiang, Yong-Hua Cheng, Yan-Li Gu. The effect of QuYuHuaTanTongLuo Decoction on the non-alcoholic steatohepatitis. Complementary Therapies in Medicine 2008; 16(4): 192 doi: 10.1016/j.ctim.2007.08.004
44
Abdalrahman Fadulalseed Wedaatella, Rahaf Abdulrahman Almehery, Ranaa Mohammed Al Namar, Aishah Saeed M Shmashir, Amro Musa Alam Alhouda, Anas Ameen Fallatah, Ali Abdalla Ali Osman, Noor Hassan A Alazmi, Mohammed Ahmed M Hurubi, Zainab Abdullah Al Khuraidah, Esraa Ahmed Akili. An Overview on Diagnosis and Management of Non-alcoholic Fatty Liver Disease. International Journal Of Pharmaceutical Research And Allied Sciences 2021; 10(2): 144 doi: 10.51847/QKKcVYgTBX
45
H. Hesham A-Kader, Fayez K. Ghishan. Textbook of Clinical Pediatrics. 2012; : 2075 doi: 10.1007/978-3-642-02202-9_215
46
Long Chen, Dao-Dong Pan, Juan Zhou, Ying-Zi Jiang. Protective effect of selenium-enriched lactobacillus on CCl<sub>4</sub>-induced liver injury in mice and its possible mechanisms. World Journal of Gastroenterology 2005; 11(37): 5795-5800 doi: 10.3748/wjg.v11.i37.5795
47
Constance E. Ruhl, James E. Everhart. Epidemiology of nonalcoholic fatty liver. Clinics in Liver Disease 2004; 8(3): 501 doi: 10.1016/j.cld.2004.04.008
48
Atef M. Al-Attar. Attenuating Effect ofGinkgo bilobaLeaves Extract on Liver Fibrosis Induced by Thioacetamide in Mice. Journal of Biomedicine and Biotechnology 2012; 2012: 1 doi: 10.1155/2012/761450
49
Yu-ling Chen, Hao Li, Shu Li, Zhou Xu, Shen Tian, Juan Wu, Xin-yu Liang, Xin Li, Zi-li Liu, Jun Xiao, Jia-ying Wei, Chen-yu Ma, Kai-nan Wu, Liang Ran, Ling-quan Kong. Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01782-w
50
Jian‐Gao Fan. Epidemiology of alcoholic and nonalcoholic fatty liver disease in China. Journal of Gastroenterology and Hepatology 2013; 28(S1): 11 doi: 10.1111/jgh.12036
51
Chien-Hua Chen, Min-Ho Huang, Jee-Chun Yang, Chiu-Kue Nien, Chi-Chieh Yang, Yung-Hsiang Yeh, Sen-Kou Yueh. Prevalence and Risk Factors of Nonalcoholic Fatty Liver Disease in an Adult Population of Taiwan: Metabolic Significance of Nonalcoholic Fatty Liver Disease in Nonobese Adults. Journal of Clinical Gastroenterology 2006; 40(8): 745 doi: 10.1097/00004836-200609000-00016
52
Bi Zhao, Yuee Liu, Yi Yang, Jihui He. Association of Systemic Immune-Inflammation Index with Non-Alcoholic Fatty Liver Disease: A Population-Based Cross-Sectional Study. Risk Management and Healthcare Policy 2023; : 1581 doi: 10.2147/RMHP.S419183
53
HIROKI NISHIKAWA, YUKIO OSAKI. Non-B, non-C hepatocellular carcinoma. International Journal of Oncology 2013; 43(5): 1333 doi: 10.3892/ijo.2013.2061
54
LIANQUN JIA, NAN SONG, GUANLIN YANG, YIXIN MA, XUETAO LI, REN LU, HUIMIN CAO, NI ZHANG, MEILIN ZHU, JUNYAN WANG, XUE LENG, YUAN CAO, YING DU, YUE XU. Effects of Tanshinone IIA on the modulation of miR-33a and the SREBP-2/Pcsk9 signaling pathway in hyperlipidemic rats. Molecular Medicine Reports 2016; 13(6): 4627 doi: 10.3892/mmr.2016.5133
55
Julia O’Brien, Lawrie W. Powell. Non-alcoholic fatty liver disease: is iron relevant?. Hepatology International 2012; 6(1): 332 doi: 10.1007/s12072-011-9304-9
56
Ji Young Kim, Choae Lee, Minsuk Oh, Jee-Aee Im, Ji-Won Lee, Sang Hui Chu, Hyangkyu Lee, Justin Y. Jeon. Relationship between non-alcoholic fatty liver disease, metabolic syndrome and insulin resistance in Korean adults: A cross-sectional study. Clinica Chimica Acta 2016; 458: 12 doi: 10.1016/j.cca.2016.03.018
57
Hager H. Shaaban, Ibrahim Alzaim, Ahmed El-Mallah, Rania G. Aly, Ahmed F. El-Yazbi, Ahmed Wahid. Metformin, pioglitazone, dapagliflozin and their combinations ameliorate manifestations associated with NAFLD in rats via anti-inflammatory, anti-fibrotic, anti-oxidant and anti-apoptotic mechanisms. Life Sciences 2022; 308: 120956 doi: 10.1016/j.lfs.2022.120956
58
Tapio Vehmas, Ari Kaukiainen, Pirjo Immonen-Räihä, Martina Lohman, Katariina Luoma. Liver echogenicity: Relation to systemic blood pressure and other components of the metabolic syndrome. Ultrasound in Medicine & Biology 2005; 31(3): 293 doi: 10.1016/j.ultrasmedbio.2004.12.015
59
Achuthan Sourianarayanane, Gaurav Garg, Thomas H. Smith, Mujtaba I. Butt, Arthur J. McCullough, Bo Shen. Risk factors of non-alcoholic fatty liver disease in patients with inflammatory bowel disease. Journal of Crohn's and Colitis 2013; 7(8): e279 doi: 10.1016/j.crohns.2012.10.015
60
Abdul Sattar Arif Khammas, Hasyma Abu Hassan, Sarah Qahtan M. Salih, Hayati Kadir, Ramlah Mohamad Ibrahim, Nurul Nadiah Mohamad Nasir, Rozi Mahmud. Prevalence and risk factors of sonographically detected non alcoholic fatty liver disease in a screening centre in Klang Valley, Malaysia: an observational cross-sectional study. Porto Biomedical Journal 2019; 4(2): e31 doi: 10.1016/j.pbj.0000000000000031
61
Xiangyu Wu, Chen Gong, Justin Weinstock, Jun Cheng, Shengnan Hu, Scott A. Venners, Yi-Hsiang Hsu, Suwen Wu, Xiangdong Zha, Shanqun Jiang, Yong Li, Faming Pan, Xiping Xu. Associations of the SLCO1B1 Polymorphisms With Hepatic Function, Baseline Lipid Levels, and Lipid-lowering Response to Simvastatin in Patients With Hyperlipidemia. Clinical and Applied Thrombosis/Hemostasis 2018; 24(9_suppl): 240S doi: 10.1177/1076029618805863
62
Miao-Juan Shi, Ben-Sheng Dong, Wen-Na Yang, Shi-Bing Su, Hui Zhang. Preventive and therapeutic role of Tanshinone ⅡA in hepatology. Biomedicine & Pharmacotherapy 2019; 112: 108676 doi: 10.1016/j.biopha.2019.108676
63
L.M. Dendl, A.G. Schreyer. Steatosis hepatis – eine Herausforderung?. Der Radiologe 2012; 52(8): 745 doi: 10.1007/s00117-012-2312-5
64
Sabry M. Abdeldyem, Tarek Goda, Samy A. Khodeir, Sabry Abou Saif, Sherief Abd-Elsalam. Nonalcoholic fatty liver disease in patients with acute ischemic stroke is associated with more severe stroke and worse outcome. Journal of Clinical Lipidology 2017; 11(4): 915 doi: 10.1016/j.jacl.2017.04.115
65
Etsuko Hashimoto, Katsutoshi Tokushige. Hepatocellular carcinoma in non‐alcoholic steatohepatitis: Growing evidence of an epidemic?. Hepatology Research 2012; 42(1): 1 doi: 10.1111/j.1872-034X.2011.00872.x
66
Xiang‐lan Wei, Xiao‐qing Chen, Ru‐tang Fang, Xiao‐yan Sun, Chang‐sheng Zhu, Jie Yang, Xin Xue, Qiang Wang. Preventive Effects of Flavonoid Extracts from Ilex hainanensisMerr. on Rats with Hepatic Steatosis Induced by a High‐Fat Diet. Drug Development Research 2012; 73(6): 308 doi: 10.1002/ddr.21014
67
Deepak N Amarapurkar, Estsuko Hashimoto, Laurentius A Lesmana, José D Sollano, Pei‐Jer Chen, Khean‐Lee Goh. How common is non‐alcoholic fatty liver disease in the Asia–Pacific region and are there local differences?. Journal of Gastroenterology and Hepatology 2007; 22(6): 788 doi: 10.1111/j.1440-1746.2007.05042.x
68
Hye Ryoung Song, Kyung Eun Yun, Hye Soon Park. Relation between alanine aminotransferase concentrations and visceral fat accumulation among nondiabetic overweight Korean women. The American Journal of Clinical Nutrition 2008; 88(1): 16 doi: 10.1093/ajcn/88.1.16
69
Liu Yao, Chunjiong Wang, Xu Zhang, Liyuan Peng, Wenli Liu, Xuejiao Zhang, Yajin Liu, Jinlong He, Changtao Jiang, Ding Ai, Yi Zhu. Hyperhomocysteinemia activates the aryl hydrocarbon receptor/CD36 pathway to promote hepatic steatosis in mice. Hepatology 2016; 64(1): 92 doi: 10.1002/hep.28518
70
John Willy Haukeland, Zbigniew Konopski, Paul Linnestad, Shafiullah Azimy, Else Marit Løberg, Terese Haaland, Kåre Birkeland, Kristian Bjøro. Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease. Scandinavian Journal of Gastroenterology 2005; 40(12): 1469 doi: 10.1080/00365520500264953
71
Bingqian Wang, Wenna Li, Hezhi Fang, Huaibin Zhou. Hepatitis B virus infection is not associated with fatty liver disease: Evidence from a cohort study and functional analysis. Molecular Medicine Reports 2018;  doi: 10.3892/mmr.2018.9619
72
Chuan-Chuan Liu, Chung-Lieh Hung, Shou-Chuan Shih, Hung-Ju Ko, Yi-Ting Lu, Yih-Jer Wu, Hui-Yun Cheng, Kuang-Chun Hu, Hung-I. Yeh, Ray-E. Chang. Age-related Differences in the Clinical Presentation, Associated Metabolic Abnormality, and Estimated Cardiovascular Risks from Nonalcoholic Fatty Liver Disease: A Cross-sectional Study from Health Evaluation Center in Taiwan. International Journal of Gerontology 2010; 4(4): 184 doi: 10.1016/j.ijge.2010.11.005
73
Johanna K DiStefano. NAFLD and NASH in Postmenopausal Women: Implications for Diagnosis and Treatment. Endocrinology 2020; 161(10) doi: 10.1210/endocr/bqaa134
74
Chi Wang, Zhen-yu Jiang, Jing Wang, Jia-xin Lou, Yuan-yuan Nian, Li-xia Liu, Tong Dang, Xian-mei Meng. A small H2O-soluble ingredient of royal jelly lower cholesterol levels in liver cells by suppressing squalene epoxidase. Heliyon 2022; 8(12): e12286 doi: 10.1016/j.heliyon.2022.e12286
75
Neeraj Bhala, Jacob George. The Burden of Non-alcoholic Fatty Liver Disease (NAFLD) in the Asia Pacific Region. Current Hepatology Reports 2015; 14(2): 77 doi: 10.1007/s11901-015-0264-8
76
Jian‐Gao Fan, Toshiji Saibara, Shivakumar Chitturi, Byong Ik Kim, Joseph J Y Sung, A Chutaputti. What are the risk factors and settings for non‐alcoholic fatty liver disease in Asia–Pacific?. Journal of Gastroenterology and Hepatology 2007; 22(6): 794 doi: 10.1111/j.1440-1746.2007.04952.x
77
Hossein Bahrami. Nonalcoholic fatty liver disease in developing countries. World Journal of Gastroenterology 2005; 11(24): 3808-3809 doi: 10.3748/wjg.v11.i24.3808
78
Dimitrios Papandreou, Eleni Andreou. Role of diet on non-alcoholic fatty liver disease: An updated narrative review. World Journal of Hepatology 2015; 7(3): 575-582 doi: 10.4254/wjh.v7.i3.575
79
Mohamed H. Ahmed, Emmanuel O. Abu, Christopher D. Byrne. Non-Alcoholic Fatty Liver Disease (NAFLD): New challenge for general practitioners and important burden for health authorities?. Primary Care Diabetes 2010; 4(3): 129 doi: 10.1016/j.pcd.2010.02.004
80
U. Rajendra Acharya, U. Raghavendra, Hamido Fujita, Yuki Hagiwara, Joel EW Koh, Tan Jen Hong, Vidya K. Sudarshan, Anushya Vijayananthan, Chai Hong Yeong, Anjan Gudigar, Kwan Hoong Ng. Automated characterization of fatty liver disease and cirrhosis using curvelet transform and entropy features extracted from ultrasound images. Computers in Biology and Medicine 2016; 79: 250 doi: 10.1016/j.compbiomed.2016.10.022
81
Ming-li ZHU, An-jun LIU, Xiao-li ZHANG, Guo-rong ZHANG. Protective Effect of Cartilage-selenium Polysaccharide on Diethylnitrosamine-Induced Liver Injury in Mice and Its Possible Mechanisms. Food Science and Technology Research 2009; 15(3): 249 doi: 10.3136/fstr.15.249
82
D. Festi, A. Colecchia, T. Sacco, M. Bondi, E. Roda, G. Marchesini. Hepatic steatosis in obese patients: clinical aspects and prognostic significance. Obesity Reviews 2004; 5(1): 27 doi: 10.1111/j.1467-789X.2004.00126.x
83
Chien‐Hua Chen, Min‐Ho Huang, Jee‐Chun Yang, Chiu‐Kue Nien, Gina Doskey Etheredge, Chi‐Chieh Yang, Yung‐Hsiang Yeh, Hurng‐Sheng Wu, Sen‐Kou Yueh. Prevalence and risk factors of gallstone disease in an adult population of Taiwan: an epidemiological survey. Journal of Gastroenterology and Hepatology 2006; 21(11): 1737 doi: 10.1111/j.1440-1746.2006.04381.x
84
Atef M. Al-Attar, Hayfa A. Al-Rethea. Chemoprotective effect of omega-3 fatty acids on thioacetamide induced hepatic fibrosis in male rats. Saudi Journal of Biological Sciences 2017; 24(4): 956 doi: 10.1016/j.sjbs.2016.01.029
85
Jiannan Song, Kerry Ann Da Costa, Leslie M. Fischer, Martin Kohlmeier, Lester Kwock, Shuli Wang, Steven H. Zeisel. Polymorphism of thePEMTgene and susceptibility to nonalcoholic fatty liver disease (NAFLD). The FASEB Journal 2005; 19(10): 1266 doi: 10.1096/fj.04-3580com
86
Clare Nugent, Zobair M Younossi. Evaluation and management of obesity-related nonalcoholic fatty liver disease. Nature Clinical Practice Gastroenterology & Hepatology 2007; 4(8): 432 doi: 10.1038/ncpgasthep0879
87
Adeyinka Charles Adejumo, Samson Alliu, Tokunbo Opeyemi Ajayi, Kelechi Lauretta Adejumo, Oluwole Muyiwa Adegbala, Nnaemeka Egbuna Onyeakusi, Akintunde Micheal Akinjero, Modupeoluwa Durojaiye, Terence Ndonyi Bukong, Pavel Strnad. Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study. PLOS ONE 2017; 12(4): e0176416 doi: 10.1371/journal.pone.0176416
88
Girish K Pati, Shivaram P Singh. Nonalcoholic Fatty Liver Disease in South Asia. Euroasian Journal of Hepato-Gastroenterology 2016; 6(2): 154 doi: 10.5005/jp-journals-10018-1189
89
Yasuhiro Ito, Takeshi Kenmochi, Shintaro Shibutani, Tomohisa Egawa, Shinobu Hayashi, Atsushi Nagashima, Yuko Kitagawa. Evaluation of Predictive Factors in Patients with Nonalcoholic Fatty Liver Disease after Pancreaticoduodenectomy. The American Surgeon™ 2014; 80(5): 500 doi: 10.1177/000313481408000523
90
Jahidul Islam, Yearul Kabir. Functional and Medicinal Beverages. 2019; : 157 doi: 10.1016/B978-0-12-816397-9.00005-4
91
Keping Peng, Zengnan Mo, Guixiang Tian. Serum Lipid Abnormalities and Nonalcoholic Fatty Liver Disease in Adult Males. The American Journal of the Medical Sciences 2017; 353(3): 236 doi: 10.1016/j.amjms.2017.01.002
92
Abdul MALIK, Phaik‐Leng CHEAH, Ida Normiha HILMI, Siew Pheng CHAN, Khean‐Lee GOH. Non‐alcoholic fatty liver disease in Malaysia: A demographic, anthropometric, metabolic and histological study. Journal of Digestive Diseases 2007; 8(1): 58 doi: 10.1111/j.1443-9573.2007.00286.x
93
Kamran Bagheri Lankarani, Fariborz Ghaffarpasand, Mojtaba Mahmoodi, Mehrzad Lotfi, Nima Zamiria, Sayed Taghi Heydari, Mohammad Kazem Fallahzadeh, Najmeh Maharlouei, Meisam Babaeinejad, Soheila Mehravar, Bita Geramizadeh. Non Alcoholic Fatty Liver Disease in Southern Iran: A Population Based Study. Hepatitis Monthly 2013; 13(5) doi: 10.5812/hepatmon.9248
94
Adnan Said, Jennifer Wells. Chronic Disease Epidemiology and Control. 2010;  doi: 10.2105/9780875531922ch19
95
Zhongli Wang, Ming Xu, Jianhong Peng, Li Jiang, Zhengguo Hu, Hua Wang, Shiqing Zhou, Rui Zhou, Michael Hultström, En Yin Lai. Prevalence and associated metabolic factors of fatty liver disease in the elderly. Experimental Gerontology 2013; 48(8): 705 doi: 10.1016/j.exger.2013.05.059
96
Okka W. Hamer, Diego A. Aguirre, Giovanna Casola, Claude B. Sirlin. Imaging Features of Perivascular Fatty Infiltration of the Liver: Initial Observations. Radiology 2005; 237(1): 159 doi: 10.1148/radiol.2371041580
97
Nila Rafiq, Chunhong Bai, Yun Fang, Manirath Srishord, Arthur McCullough, Terry Gramlich, Zobair M. Younossi. Long-Term Follow-Up of Patients With Nonalcoholic Fatty Liver. Clinical Gastroenterology and Hepatology 2009; 7(2): 234 doi: 10.1016/j.cgh.2008.11.005
98
Timothy P. Gill. Clinical Obesity in Adults and Children. 2005; : 429 doi: 10.1002/9780470987087.ch29
99
Yan Zhang, Xian-hui Qin, Jian-ping Li, Yi-min Cui, Ze-yuan Liu, Zhi-gang Zhao, Jun-bo Ge, De-ming Guan, Jian Hu, Yan-ni Wang, Fu-min Zhang, Xin Xu, Xi-ping Xu, Yong Huo. Factors underlying the association of body mass index with serum ALT in Chinese hypertensive adults without known hepatic diseases. Journal of Zhejiang University SCIENCE B 2013; 14(8): 743 doi: 10.1631/jzus.B1200330
100
Julius Henning Niehoff, Matthias Michael Woeltjen, Saher Saeed, Arwed Elias Michael, Jan Boriesosdick, Jan Borggrefe, Jan Robert Kroeger. Assessment of hepatic steatosis based on virtual non-contrast computed tomography: Initial experiences with a photon counting scanner approved for clinical use. European Journal of Radiology 2022; 149: 110185 doi: 10.1016/j.ejrad.2022.110185
101
Tingting Ren, Chao Huang, Mingliang Cheng. Dietary Blueberry and Bifidobacteria Attenuate Nonalcoholic Fatty Liver Disease in Rats by Affecting SIRT1-Mediated Signaling Pathway. Oxidative Medicine and Cellular Longevity 2014; 2014: 1 doi: 10.1155/2014/469059
102
Ali Akbar Hajiaghamohammadi, Amir Ziaee, Rasoul Samimi. The Efficacy of Licorice Root Extract in Decreasing Transaminase Activities in Non‐alcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial. Phytotherapy Research 2012; 26(9): 1381 doi: 10.1002/ptr.3728
103
Anuradha S Dassanayake, Anuradhani Kasturiratne, Shaman Rajindrajith, Udaya Kalubowila, Sureka Chakrawarthi, Arjuna P De Silva, Miyuki Makaya, Tetsuya Mizoue, Norihiro Kato, A. Rajitha Wickremasinghe, H. Janaka De Silva. Prevalence and risk factors for non‐alcoholic fatty liver disease among adults in an urban Sri Lankan population. Journal of Gastroenterology and Hepatology 2009; 24(7): 1284 doi: 10.1111/j.1440-1746.2009.05831.x
104
Wenwang Rao, Yingying Su, Guang Yang, Yue Ma, Rui Liu, Shangchao Zhang, Shibin Wang, Yingli Fu, Changgui Kou, Yaqin Yu, Qiong Yu. Cross-Sectional Associations between Body Mass Index and Hyperlipidemia among Adults in Northeastern China. International Journal of Environmental Research and Public Health 2016; 13(5): 516 doi: 10.3390/ijerph13050516
105
Bashu Dev Pardhe, Shreena Shakya, Anjeela Bhetwal, Jennifer Mathias, Puspa Raj Khanal, Roshan Pandit, Jyotsna Shakya, Hari Om Joshi, Sujan Babu Marahatta. Metabolic syndrome and biochemical changes among non-alcoholic fatty liver disease patients attending a tertiary care hospital of Nepal. BMC Gastroenterology 2018; 18(1) doi: 10.1186/s12876-018-0843-6
106
Ying Li, Jinyan Zhao, Haiyin Zheng, Xiaoyong Zhong, Jianheng Zhou, Zhenfeng Hong, I-Min Liu. Treatment of Nonalcoholic Fatty Liver Disease with Total Alkaloids in Rubus aleaefolius Poir through Regulation of Fat Metabolism. Evidence-Based Complementary and Alternative Medicine 2014; 2014(1) doi: 10.1155/2014/768540
107
Adnan Said. CHRONIC DISEASE EPIDEMIOLOGY, PREVENTION, AND CONTROL, 4th edition. 2016;  doi: 10.2105/9780875532783ch21
108
H. Hesham A-Kader. Nonalcoholic fatty liver disease in children living in the obeseogenic society. World Journal of Pediatrics 2009; 5(4): 245 doi: 10.1007/s12519-009-0048-8
109
Jian-Gao Fan, Geoffrey C. Farrell. Epidemiology of non-alcoholic fatty liver disease in China. Journal of Hepatology 2009; 50(1): 204 doi: 10.1016/j.jhep.2008.10.010
110
Yuichiro Eguchi, Toshihiko Mizuta, Iwata Ozaki, Dita Salova, Masato Yoneda, Koji Fujita, Hideyuki Hyogo, Hideki Fujii, Masafumi Ono, Yasuaki Suzuki, Takaaki Ohtake, Yoshio Sumida, Kazuma Fujimoto. Handbook of Anthropometry. 2012; : 2213 doi: 10.1007/978-1-4419-1788-1_136
111
Janus P. Ong, Zobair M. Younossi. Epidemiology and Natural History of NAFLD and NASH. Clinics in Liver Disease 2007; 11(1): 1 doi: 10.1016/j.cld.2007.02.009
112
JIAN‐GAO FAN, JUNE ZHU, XING‐JIAN LI, LAN CHEN, YUAN‐SAN LU, LUI LI, FEI DAI, FENG LI, SHI‐YAO CHEN. Fatty liver and the metabolic syndrome among Shanghai adults. Journal of Gastroenterology and Hepatology 2005; 20(12): 1825 doi: 10.1111/j.1440-1746.2005.04058.x
113
Hiroyuki Kato, Shuji Isaji, Yoshinori Azumi, Masashi Kishiwada, Takashi Hamada, Shugo Mizuno, Masanobu Usui, Hiroyuki Sakurai, Masami Tabata. Development of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) after pancreaticoduodenectomy: proposal of a postoperative NAFLD scoring system. Journal of Hepato-Biliary-Pancreatic Sciences 2010; 17(3): 296 doi: 10.1007/s00534-009-0187-2
114
Shao‐Jun Xiao, Guang‐Jian Fu, Ya‐Lan Lv, Xiao‐Ni Zhong, Run‐Hua Wang. Prevalence and risk factors of fatty liver disease in young and middle‐aged population: One center study in southwestern China. Journal of Gastroenterology and Hepatology 2014; 29(2): 358 doi: 10.1111/jgh.12334
115
Rui Fan, Jufang Wang, Jinman Du. Association between body mass index and fatty liver risk: A dose-response analysis. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-33419-6
116
Jiyun Ahn, Iljin Cho, Suna Kim, Daeyoung Kwon, Taeyoul Ha. Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet. Journal of Hepatology 2008; 49(6): 1019 doi: 10.1016/j.jhep.2008.08.012
117
Yan-Jun Luo, Jie-Ping Yu, Zhao-Hong Shi, Li Wang. Ginkgo biloba extract reverses CCl<sub>4</sub>&ndash;induced liver fibrosis in rats. World Journal of Gastroenterology 2004; 10(7): 1037-1042 doi: 10.3748/wjg.v10.i7.1037
118
Ajay Duseja, Naga Chalasani. Epidemiology and risk factors of nonalcoholic fatty liver disease (NAFLD). Hepatology International 2013; 7(S2): 755 doi: 10.1007/s12072-013-9480-x
119
Jia Xiao, Kwok Fai So, Emily C. Liong, George L. Tipoe. Recent Advances in the Herbal Treatment of Non-Alcoholic Fatty Liver Disease. Journal of Traditional and Complementary Medicine 2013; 3(2): 88 doi: 10.4103/2225-4110.110411
120
Amedeo Lonardo, Stefano Bellentani, Curtis K. Argo, Stefano Ballestri, Christopher D. Byrne, Stephen H. Caldwell, Helena Cortez-Pinto, Antonio Grieco, Mariana V. Machado, Luca Miele, Giovanni Targher. Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups. Digestive and Liver Disease 2015; 47(12): 997 doi: 10.1016/j.dld.2015.08.004
121
Man-Man Wang, Gong-Sui Wang, Feng Shen, Guang-Yu Chen, Qin Pan, Jian-Gao Fan. Hepatic Steatosis Is Highly Prevalent in Hepatitis B Patients and Negatively Associated with Virological Factors. Digestive Diseases and Sciences 2014; 59(10): 2571 doi: 10.1007/s10620-014-3180-9
122
Mika Yamamoto, Motoh Iwasa, Kazuko Iwata, Masahiko Kaito, Ryosuke Sugimoto, Naohito Urawa, Rumi Mifuji, Masayoshi Konishi, Yoshinao Kobayashi, Yukihiko Adachi. Restriction of dietary calories, fat and iron improves non‐alcoholic fatty liver disease. Journal of Gastroenterology and Hepatology 2007; 22(4): 498 doi: 10.1111/j.1440-1746.2006.04548.x
123
Walter Futterweit. Insulin Resistance and Polycystic Ovarian Syndrome. 2007; : 303 doi: 10.1007/978-1-59745-310-3_23
124
Martin C. S. Wong, Jason L. W. Huang, Jacob George, Junjie Huang, Colette Leung, Mohammed Eslam, Henry L. Y. Chan, Siew C. Ng. The changing epidemiology of liver diseases in the Asia–Pacific region. Nature Reviews Gastroenterology & Hepatology 2019; 16(1): 57 doi: 10.1038/s41575-018-0055-0
125
Maya Gambarin–Gelwan, Sanjiv V. Kinkhabwala, Thomas D. Schiano, Carol Bodian, Hsu–Chong Yeh, Walter Futterweit. Prevalence of Nonalcoholic Fatty Liver Disease in Women With Polycystic Ovary Syndrome. Clinical Gastroenterology and Hepatology 2007; 5(4): 496 doi: 10.1016/j.cgh.2006.10.010
126
Emmi Suomela, Mervi Oikonen, Johanna Virtanen, Riitta Parkkola, Eero Jokinen, Tomi Laitinen, Nina Hutri-K&auml;h&ouml;nen, Mika K&auml;h&ouml;nen, Terho Lehtim&auml;ki, Leena Taittonen, P&auml;ivi Tossavainen, Antti Jula, Britt-Marie Loo, Vera Mikkil&auml;, Zobair Younossi, Jorma S. A. Viikari, Markus Juonala, Olli T. Raitakari. Prevalence and determinants of fatty liver in normal-weight and overweight young adults. The Cardiovascular Risk in Young Finns Study. Annals of Medicine 2015; 47(1): 40 doi: 10.3109/07853890.2014.966752
127
Hiroshi Sakugawa, Tomofumi Nakayoshi, Kasen Kobashigawa, Hiroki Nakasone, Yuko Kawakami, Tsuyoshi Yamashiro, Tatsuji Maeshiro, Ko Tomimori, Satoru Miyagi, Fukunori Kinjo, Atsushi Saito. Metabolic syndrome is directly associated with gamma glutamyl transpeptidase elevation in Japanese women. World Journal of Gastroenterology 2004; 10(7): 1052-1055 doi: 10.3748/wjg.v10.i7.1052
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345